| Model Number |
PB1016 |
| Medical Device Problem Codes |
Gradient Increase (1270); Mechanical Problem (1384)
|
| Health Effect - Clinical Codes |
Pulmonary Valve Stenosis (2024); Pulmonary Valve Insufficiency/ Regurgitation (4452); Pulmonary Hypertension (4460)
|
| Date of Event |
03/01/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Medtronic received information that approximately six years and two months following the implant of this transcatheter bioprosthetic pulmonary valve, the valve was re-dilated as a result of pulmonary stenosis.Valve stenosis and moderate pulmonary regurgitation (pr) with a gradient across the valve were reported.Approximately six years and eleven months following the valve implant, increased right ventricle pressures, reported as 3/4 the systemic pressure, moderate pr and a gradient of 30 millimeters of mercury (mmhg) across the pulmonary valve were reported.A palmaz stent and new melody valve were implanted.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.Of note, date of event is an approximation.The exact date of the re-dilation was not reported.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information was received that outgrowth was potentially a factor in the replacement, however the physician could not be certain.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: b5 - additional information was received that the second melody valve was implanted approximately six years and ten months following the initial valve implant.No additional adverse patient effects were reported.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|